由CO.DON GmbH牵头的欧盟微型2MACRO发射项目,通过生物印刷推进组织再生。 EU project micro2MACRO launches to advance tissue regeneration via bioprinting, led by CO.DON GmbH.

欧盟资助的微型2MACRO项目于2024年12月启动,旨在通过创新的生物印刷促进组织再生。 The EU-funded micro2MACRO project, launched in December 2024, aims to advance tissue regeneration through innovative bioprinting. 该项目由CO.DON GmbH牵头,涉及顶尖的学术和研究机构,开发可定制的用于组织修复的移植物。 Led by CO.DON GmbH, the project involves top academic and research institutions to develop customizable grafts for tissue repair. CO.DON拥有30多年的再生医学,提供细胞治疗的专门知识。 CO.DON, with over 30 years in regenerative medicine, contributes expertise in cell-based therapies. 该项目还侧重于通过欧洲各地的讲习班和知识交流提高技能。 The project also focuses on enhancing skills through workshops and knowledge exchange across Europe.